Westfield Capital Management
PFE icon

Westfield Capital Management’s Pfizer PFE Stock Holding History

Westfield Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
162,023
+28,289
+21% +$740K 0.01% 245
2026
Q1 		$3.76M Sell
133,734
-4,202
-3% -$112K 0.02% 211
2025
Q4 		$3.43M Buy
+137,936
New +$3.48M 0.01% 218
2025
Q2 		– Sell
-315,697
Closed -$8M – 266
2025
Q1 		$8M Sell
315,697
-22,019
-7% -$576K 0.04% 190
2024
Q4 		$8.96M Buy
337,716
+2,160
+0.6% +$58.6K 0.04% 190
2024
Q3 		$9.71M Buy
335,556
+60,378
+22% +$1.76M 0.04% 198
2024
Q2 		$7.7M Buy
275,178
+20,888
+8% +$575K 0.04% 204
2024
Q1 		$7.06M Buy
+254,290
New +$7.06M 0.04% 207
2020
Q1 		– Sell
-147,444
Closed -$5.48M – 248
2019
Q4 		$5.48M Sell
147,444
-482
-0.3% -$17.2K 0.04% 201
2019
Q3 		$5.04M Buy
+147,926
New +$5.38M 0.04% 206
2016
Q4 		– Sell
-179,893
Closed -$5.78M – 284
2016
Q3 		$5.78M Hold
179,893
– – 0.05% 213
2016
Q2 		$6.01M Hold
179,893
– – 0.05% 213
2016
Q1 		$5.06M Buy
179,893
+9,171
+5% +$262K 0.04% 211
2015
Q4 		$5.23M Buy
170,722
+15,990
+10% +$503K 0.04% 217
2015
Q3 		$4.61M Sell
154,732
-475
-0.3% -$15.2K 0.03% 209
2015
Q2 		$4.94M Buy
155,207
+13,702
+10% +$447K 0.03% 232
2015
Q1 		$4.67M Buy
141,505
+29,280
+26% +$931K 0.03% 247
2014
Q4 		$3.32M Buy
112,225
+4,132
+4% +$118K 0.02% 250
2014
Q3 		$3.03M Buy
108,093
+8,474
+9% +$238K 0.02% 242
2014
Q2 		$2.81M Buy
99,619
+25,064
+34% +$714K 0.02% 243
2014
Q1 		$2.27M Buy
74,555
+5,608
+8% +$167K 0.01% 255
2013
Q4 		$2M Hold
68,947
– – 0.01% 248
2013
Q3 		$1.88M Sell
68,947
-4,058,599
-98% -$110M 0.01% 258
2013
Q2 		$110M Buy
+4,127,546
New +$114M 0.75% 35

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westfield Capital Management's PFE Position: Q2 2026 in Review

Westfield Capital Management increased its Pfizer (PFE) stake by 21% in Q2 2026, buying an estimated $740K and bringing the position to 162,023 shares worth $3.9M. The position accounts for 0.01% of the portfolio, ranked #245.

Westfield Capital Management first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $110M in Q2 2013. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Westfield Capital Management held 162,023 shares of Pfizer worth $3.9M as of Q2 2026.
  • Westfield Capital Management bought 28,289 Pfizer shares in Q2 2026, an estimated $740K.
  • Pfizer made up 0.01% of Westfield Capital Management's portfolio in Q2 2026, its #245 holding.
  • Westfield Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • Westfield Capital Management's Pfizer position peaked at $110M in Q2 2013.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.